ProfileGDS4459 / ENSG00000162552
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 65% 48% 31% 62% 40% 35% 40% 40% 37% 43% 32% 34% 38% 51% 35% 36% 23% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.9865
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.3548
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.5531
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.9162
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 5440
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.8635
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.0140
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.9640
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.8437
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.1443
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.6832
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.7134
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.9538
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.4451
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.7635
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.9736
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.4823